Company page

Cogent Biosciences, Inc.

Cogent Biosciences, Inc. (ticker: COGT) is a public company operating in the American market. With a market capitalization of approximately $5.9 billion, Cogent focuses on developing innovative therapies for diseases driven by genetic mutations. The company's commitment to advancing precision medicine positions it as a key player in the biotechnology sector.